Holding(s) in Company | RNS | Ticker

Holding(s) in Company

RNS Announcement

RNS Number : 0910N

AstraZeneca PLC

13 May 2015


TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESⁱ

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ⁱⁱ		AstraZeneca PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: ⁱⁱⁱ	The Capital Group Companies, Inc.
4. Full name of shareholder(s) (if different from 3.):^iv	See Schedule A
5. Date of the transaction and date on which the threshold is crossed or reached: ^v	11 May 2015
6. Date on which issuer notified:	12 May 2015
7. Threshold(s) that is/are crossed or reached: ^{vi, vii}	Above 3%

8. Notified details:

A: Voting rights attached to shares ^{viii, ix}

Class/type of
shares

if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights ^x

Direct

Direct ^xi

Indirect ^xii

Direct

Indirect

Ordinary Shares

(ISIN: GB0009895292)

32,100,333

32,139,533

2.544%

ADRs

(ISIN: US0463531089)

5,767,760

5,768,891

0.457%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date ^xiii

Exercise/
Conversion Period ^xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ^{xv, xvi}

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date ^xvii

Exercise/
Conversion period ^xviii

Number of voting rights instrument refers to

% of voting rights ^{xix, xx}

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

37,908,424

3.000%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ^xxi
See Schedule A

Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:
14. Contact name:	Martin Bennett, Assistant Company Secretary
15. Contact telephone number:	020 7604 8157

Schedule A

As of 11 May 2015

AstraZeneca PLC

	Number of Shares	Percent of Outstanding

The Capital Group Companies, Inc. ("CG") holdings	37,908,424	3.000%
Holdings by CG Management Companies and Funds:
Capital Guardian Trust Company	5,439,762	0.431%
Capital International Limited	165,000	0.013%
Capital International Sàrl	153,792	0.012%
Capital International, Inc.	72,300	0.006%
Capital Research and Management Company	32,077,570	2.539%

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLBXGDUCSBBGUX

RNS metadata

Title: Holding(s) in Company
Time: 16:00:04
Date: 13 May 2015
Category: Holding(s) in company
ID: 0910N